RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/36241425http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/36241425http://www.w3.org/2000/01/rdf-schema#comment"New therapeutic targets are a valuable resource for treatment of SARS-CoV-2 viral infection. Genome-wide association studies have identified risk loci associated with COVID-19, but many loci are associated with comorbidities and are not specific to host-virus interactions. Here, we identify and experimentally validate a link between reduced expression of EXOSC2 and reduced SARS-CoV-2 replication. EXOSC2 was one of the 332 host proteins examined, all of which interact directly with SARS-CoV-2 proteins. Aggregating COVID-19 genome-wide association studies statistics for gene-specific eQTLs revealed an association between increased expression of EXOSC2 and higher risk of clinical COVID-19. EXOSC2 interacts with Nsp8 which forms part of the viral RNA polymerase. EXOSC2 is a component of the RNA exosome, and here, LC-MS/MS analysis of protein pulldowns demonstrated interaction between the SARS-CoV-2 RNA polymerase and most of the human RNA exosome components. CRISPR/Cas9 introduction of nonsense mutations within EXOSC2 in Calu-3 cells reduced EXOSC2 protein expression and impeded SARS-CoV-2 replication without impacting cellular viability. Targeted depletion of EXOSC2 may be a safe and effective strategy to protect against clinical COVID-19."xsd:string
http://purl.uniprot.org/citations/36241425http://purl.org/dc/terms/identifier"doi:10.26508/lsa.202201449"xsd:string
http://purl.uniprot.org/citations/36241425http://purl.uniprot.org/core/author"Franklin J."xsd:string
http://purl.uniprot.org/citations/36241425http://purl.uniprot.org/core/author"Zhang S."xsd:string
http://purl.uniprot.org/citations/36241425http://purl.uniprot.org/core/author"Gordon D."xsd:string
http://purl.uniprot.org/citations/36241425http://purl.uniprot.org/core/author"Collins M.O."xsd:string
http://purl.uniprot.org/citations/36241425http://purl.uniprot.org/core/author"Shaw P.J."xsd:string
http://purl.uniprot.org/citations/36241425http://purl.uniprot.org/core/author"Krogan N."xsd:string
http://purl.uniprot.org/citations/36241425http://purl.uniprot.org/core/author"Snyder M.P."xsd:string
http://purl.uniprot.org/citations/36241425http://purl.uniprot.org/core/author"Hautbergue G."xsd:string
http://purl.uniprot.org/citations/36241425http://purl.uniprot.org/core/author"Ferraiuolo L."xsd:string
http://purl.uniprot.org/citations/36241425http://purl.uniprot.org/core/author"Rehwinkel J."xsd:string
http://purl.uniprot.org/citations/36241425http://purl.uniprot.org/core/author"Harvey C."xsd:string
http://purl.uniprot.org/citations/36241425http://purl.uniprot.org/core/author"Moll T."xsd:string
http://purl.uniprot.org/citations/36241425http://purl.uniprot.org/core/author"Cooper-Knock J."xsd:string
http://purl.uniprot.org/citations/36241425http://purl.uniprot.org/core/author"Castelli L."xsd:string
http://purl.uniprot.org/citations/36241425http://purl.uniprot.org/core/author"Odon V."xsd:string
http://purl.uniprot.org/citations/36241425http://purl.uniprot.org/core/author"Marshall J.N."xsd:string
http://purl.uniprot.org/citations/36241425http://purl.uniprot.org/core/author"Azzouz M."xsd:string
http://purl.uniprot.org/citations/36241425http://purl.uniprot.org/core/author"Peden A."xsd:string
http://purl.uniprot.org/citations/36241425http://purl.uniprot.org/core/author"Dos Santos Souza C."xsd:string
http://purl.uniprot.org/citations/36241425http://purl.uniprot.org/core/author"Graves E."xsd:string
http://purl.uniprot.org/citations/36241425http://purl.uniprot.org/core/date"2023"xsd:gYear
http://purl.uniprot.org/citations/36241425http://purl.uniprot.org/core/name"Life Sci Alliance"xsd:string